Conexeu Sciences Inc. fell 10.2% on Friday, October 30, 2026, on 516,856 shares. No headline about CNXU came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Conexeu Sciences Inc. (CNXU:NASDAQ) closed at $2.54 on October 30, 2026, down 10.25% on the day. The stock trades 86.5% below its 52-week high of $18.79 and 4.5% above its 52-week low of $2.43. Over the past year, it lost 80.6%. Conexeu Sciences Inc. is part of the Health Care sector.
In 112 trading sessions since May 22, 2026, CNXU closed higher on 43 days (38%). Its best day was June 16, 2026 (+27.49%) and its worst was October 16, 2026 (-22.53%). The stock moved 10% or more in a single session 26 times. It opened at least 5% above the previous day's high 3 times.
Conexeu Sciences is a preclinical-stage regenerative tissue platform company. Our patented bioregenerative extracellular matrix (ECM) platform, CXU¿, is built on a single structural principle: one formula, one device, designed to scale across multiple addressable markets without reformulation. CXU¿ is designed to restore soft tissue lost through injury, aging, and GLP-1-associated tissue related weight loss. The Company's lead product, Ten Minute Tissue¿, is a CXU-based injectable ECM that remains fluid at room temperature and transitions to a stable gel in situ at body temperature within approximately ten minutes. In preclinical studies, Ten Minute Tissue¿ has demonstrated enhanced healing dynamics, organized scaffold formation, and a favorable (low) inflammatory profile, collectively supporting cell migration, proliferation, differentiation, and new tissue formation.
Find more stocks like CNXU with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.